The results of bioinformatic analysis suggested that KK-LC-1 expression was molecular subtype-specific [9, 19, 20], and KK-LC-1 was mainly expressed in triple-negative breast cancer [21–23]. This evidence concerns the gene CT83 and triple-negative breast carcinoma.